Search Results 101-110 of 23492 for ulcerative colitis

  1. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  2. A Study to Evaluate Effectiveness and Safety of TD-1473 in Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis with up to 60 weeks of treatment. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  3. abdominal pain Archives - Mayo Clinic News Network

    severity of inflammation and where it occurs. Therefore, doctors often classify ulcerative colitis according to its location. Signs and Symptoms Diarrhea, often ...

  4. A Study Of The Effectiveness And Safety Of Vedolizumab Compared To Adalimumab For Participants With Ulcerative Colitis - Mayo Clinic

    Clinical Trials · A Study Of The Effectiveness And Safety Of Vedolizumab Compared To Adalimumab For Participants With Ulcerative Colitis · More about research at ...

  5. Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  6. Balsalazide (oral route) - Side effects & dosage - Mayo Clinic

    Balsalazide capsules are used to treat mild to moderately active ulcerative colitis in patients 5 years of age and older. Balsalazide tablets are used to ...

  7. Pseudomembranous colitis - Symptoms & causes - Mayo Clinic

    Colitis is inflammation of the colon. Inflammation is the immune system reaction to disease or injury. An inflammatory reaction increases blood flow, releases ...

  8. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  9. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  10. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...